Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma.

Hao, Xiaoxiao; Wei, Yongqiang; Wei, Xiaolei; Zhou, Lizhi; Wei, Qi; Zhang, Yuankun; Huang, Weimin; Feng, Ru

Hao, Xiaoxiao; Wei, Yongqiang; Wei, Xiaolei; Zhou, Lizhi; Wei, Qi; Zhang, Yuankun; Huang, Weimin; Feng, Ru.

Afiliación

Hao X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wei Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wei X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhou L; Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China.
Wei Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Huang W; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Feng R; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Oncotarget ; 8(44): 76740-76748, 2017 Sep 29.

Article en En | MEDLINE | ID: mdl-29100345

Palabras clave

diffuse large B-cell lymphoma; glasgow prognostic score; inflammation-based prognostic score

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google